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Background: Prostate diseases are  a common problem worldwide. This study was aimed at 
o establishing the clinical characteristics of patients diagnosed to have prostate diseases in 
the Moi Teaching and Referral Hospital (MTRH) in Eldoret, Kenya. 
Methods: This was a cross-sectional, hospital based, descriptive study undertaken in the 
Urology Outpatient Clinic and Surgical Ward of MTRH.  A total of 219 patients aged 50 
years and above with prostate diseases were recruited into an Institutional Research and 
Ethics Committee (IREC) approved study after granting a formal consent. The primary 
outcome measure was the clinical characteristics of patients with acute prostatitis, Benign 
Prostate Hyperplasia (BPH) and Prostate Cancer in MTRH. The secondary outcome 
measures were the demographic data and co morbidities. 
Results: Patients’ ages ranged from 50 to 96 years with a mean of 65.4  s.d. ± 10.2 years. 
The majority (68%) of them presented with a past history of urinary retention; 71.7% had 
palpably enlarged prostate on DRE. The annual incidence of prostate diseases in the 
Urology Clinic was 31.1% with the prevalence of Acute Prostatitis, BPH and Prostate Cancer 
being 1.8%, 63.9% and 34.3% respectively. Only 28.3% of the patients had PSA levels in the 
laboratory normal range of 0-4ng/ml. There was a 32.4% surgical rate in the care of these 
patients with   Trans-Urethral Resection of the Prostate (TURP) accounting for 57.8% of the 
surgeries and 68.3% of the operations on the prostate.   
Conclusion: Benign Prostate Hyperplasia (BPH) is the leading clinical pathology in 
indigenous black African patients presenting with prostate diseases in MTRH despite high 
PSA levels. Majority of these patients have enlarged prostates and history of urine 
retention. 
Recommendations: The standard approaches of clinical assessment and PSA are wanting in 
many aspects and the Caucasian studies may not truly reflect on indigenous black Africans. 
It is recommended that this be borne in mind as diagnoses of the various prostate diseases 
are made. 
Introduction 
Prostate diseases are common the world over irrespective of races with majority of men likely 
to develop one or the other of the three main conditions of Prostatitis, Benign Prostate 
Hyperplasia (BPH) and Prostate Cancer 1. Inflammation is a common denominator in the three 
conditions 2-4 and potential link exists between both urinary tract infection and sexually 
transmitted diseases in the final occurrence of prostate cancer 5. While evidence points to racial 
and geographical differences in the presentation of prostate diseases 5, much of the available 
data has been gathered from European and American studies and may not comprehensively 
address the problem among the African population 6-7. This study shares the experience with 
prostate diseases in a tertiary centre dealing with African men and brings into focus the striking 
differences in the data when compared with the Western statistics. 
Patients and Methods 
Patients of indigenous Black African extraction based on birth and exclusive residence in Africa 
presenting to the urology clinic or admitted with lower urinary tract symptoms ascribable to 
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the prostate and diagnosed to have Acute Prostatitis, Benign Prostate Hyperplasia (BPH) or 
Prostate Cancer had their demographic data taken after formally consenting to participate in 
the study. Those with urethral strictures or considered to have other non-prostatic causes of 
bladder outlet obstruction were excluded. Clinical assessment included standard physical 
examination with a focused Digital Rectal Examination (DRE). Clinical diagnosis of Prostatitis 
was limited to the acute form and based on findings of a tender prostate with features of an 
acute inflammatory process. Benign Prostate Hyperplasia was considered where the examining 
urologist made findings in keeping with a benign prostate enlargement with no asymmetry or 
nodulations and having freely mobile overlying mucosa. The Prostate Specific Antigen (PSA) 
levels were determined in the standard laboratory procedure using Abbott IMx assay with a 0-
4ng/ml normal range within 24 hours of submission of blood in plain specimen bottles. Patients 
who underwent prostate surgery or had a prostate biopsy taken on suspicion of malignancy had 
histological confirmation of the prostate disease. Data was ethically collected using a pre-
designed data sheet, entered in a spreadsheet, confirmed for completeness, cleaned and then 
analyzed using Scientific Program for Social Sciences (SPSS) version 17.0 with focus on the 
primary and secondary outcome measures. The findings were in descriptive terms and relied on 
measures of central tendency as well as measures of dispersion. They are presented in tables 
and narratives.  
Results 
During the one year study period, 842 new patients were attended to in the urology clinic of 
MTRH. A total of 262 patients were diagnosed to have one of the three prostate diseases namely 
Prostatitis, BPH and Prostate Cancer giving an annual incidence of 31.1%. Forty-three patients 
with either associated urethral strictures independent of prostatic stenosis or suspected 
neurogenic bladder besides prostate enlargement were excluded from the study. The 219 
patients recruited into the study were 163 inpatients (74.4%) and 56 outpatients. The age range 
was between 50 and 96 years with a mean ± standard deviation of 65.4 ± 10.2 years. Table 1 
shows the demographic features of the patients. As of the time of presentation, 68% of patients 
had had a history of urine retention. On digital rectal examination, 157 patients (71.7%) had 
palpably enlarged prostate and other abnormalities like asymmetry, immobile overlying 
mucosa and nodularity. Clinical diagnosis of Acute Prostatitis was made in 4, BPH in 140 and 
Prostate Cancer in 75 patients, giving disease prevalence of 1.8%, 63.9% and 34.3% 
respectively. Patient complaints and chief findings on examination are as shown in Table 2.    
Table 1. Demographic Features of the Patients 
Variable Frequency Percentage 
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                   56 
 
                 74.4% 
                 25.6% 
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Table 2. Clinical Features of the 219 Patients at Presentation 
Variable                Number Percentage 
Urine retention 149 68.0% 
Weak flow of urine 149 68.0% 
Incomplete voiding 147 67.1% 
Frequent urination at night 109 49.8% 
Burning sensation during urination 71 32.4% 























Table 3. Distribution of PSA Levels among Prostate Diseases 
Disease    PSA≤4ng/ml PSA>4ng/ml Total 
Ca Prostate 14(18.7%) 61(81.3%) 75 
BPH 46(32.9%) 94(67.1%) 140 
Prostatitis 2(50%) 2(50%) 4 
Total  62(41.6%) 157(58.4%) 219 
 
The 219 study subjects had a mean PSA level of 31.2ng/ml and only 62 patients (28.3%) had 
PSA within the laboratory reference of normal range 0-4ng/ml with an average of 1.8 ng/ml. 
Those with elevated PSA levels had a mean of 42.3ng/ml. Table 3 shows the distribution of the 
PSA levels among the three conditions. Twenty-four patients (18.6%) had associated 
genitourinary problems: 12 orchitis and 12 hydroceles. Surgical interventions were instituted 
on 71 patients, giving a 32.4% surgical rate in the care of these patients.  Trans-Urethral 
Resection of the Prostate (TURP) accounted for 57.8% of the surgeries and 68.3% of the 
operations on the prostate.  Orchidectomy was done on 11 patients during the study period. 
Fifty-four patients had prostate biopsy submitted for histology. Forty of them (74.1%) were 
found to be malignant and 38 of these had been correctly diagnosed as such. The other 35 
patients clinically diagnosed of Prostate Cancer were on the basis of DRE and were all having 
PSA in excess of 100 ng/ml. Two patients with PSA levels within the 0-4ng/ml normal range had 
histological finding of malignancy.  
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Prostate diseases are so common in urological practice that one’s age after 60 years could easily 
be the percentage of those affected in that age group 1. While mechanisms leading to each of the 
pathologies have been extensively elucidated, there seem to exist racial and geographical 
differences on how the diseases present 6-7 and as such an attempt at establishing 
characteristics typical of our African patients goes a long way in filling the void created by over 
reliance on data generated elsewhere. 
The age of our patients compares well with that of the rest in the world but that seems to be end 
of the similarities. While less than 10% present with urinary retention elsewhere 8, this study 
had a urinary retention rate of 68%. The attendant complications including urinary tract 
infections and pressure effects on the urinary tract could explain the co morbidities noted like 
hydroceles and orchitis. Urine reflux into the prostate under pressure voiding has been 
postulated to be one of the noninfectious causes of chronic prostatic inflammation that may 
reflect on any of the prostate diseases 2. The close to 72% rate of abnormal findings on DRE may 
suggest the consistent finding of delayed presentation of our patients. Rufus and colleagues in 
Nigeria found an abnormal DRE to be an independent predictor of high grade prostate tumour 9. 
Their malignancy detection rate of 43.2% compared to our 34.3% may, however, suggest even a 
greater delay in their setting.  
While studies have shown the great benefits of combining DRE and Prostate Specific Antigen 
(PSA) levels in the evaluation of the patient with prostate disease 10, it is also emerging that the 
man over 50 years may require further evaluation beyond these two diagnostic processes since 
some studies have shown up to 40% of histologically identified cancer of prostate in patients 
with normal DRE and PSA findings 11. Young and Young found that only the highly elevated PSA 
was clearly indicative of malignancy 8 and only levels in excess of 100ng/ml could give 100% 
predictive value. This could explain in part why PSA figures may not be exclusively categorical 
for any of the prostate diseases as noted in this study. It seems to be even a greater challenge in 
this unexplored African peculiarity of generally high levels of PSA and a small number that may 
even have malignancy in the normal range reflected by the two patients in our study.  
Our interventions seem to reflect the global trend towards non surgical management of prostate 
diseases while at the same time encompassing the wide range from medical therapy to palliative 
orchidectomy for advanced prostate cancer. Our TURP rate of 68.3% compares favourably with 
local and international counterparts 11.  
 Conclusion 
Benign Prostate Hyperplasia (BPH) is the leading clinical pathology in indigenous  black African 
patients presenting in MTRH with prostate diseases despite high PSA levels. Majority of these 
patients have enlarged prostates and history of urine retention. 
Recommendations 
The standard approaches of clinical assessment and PSA are wanting in many aspects and the 
Caucasian studies may not truly reflect on indigenous black Africans. It is recommended that 
this be borne in mind as diagnoses of the various prostate diseases are made. 
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